Mary Jo Murnane
- Molecular Biology
- Cancer Research top 5%
- Oncology top 10%
- Genetics top 5%
- Physiology
- Co-authors
- Sania ShujaKieran SheahanKwonseop KimMetin ÖzdemirliBernard G. ForgetJon K. deRielF.H. RuddleDorothy Tuan
- Topics
- Protease and Inhibitor Mechanisms (10 papers)Peptidase Inhibition and Analysis (5 papers)Bone and Dental Protein Studies (4 papers)
- Partner nations
- United StatesNetherlandsSouth Korea
In The Last Decade
Mary Jo Murnane
32 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 96
- Molecular Biology 637
- Cancer Research 378
- Oncology 242
- Genetics 172
- Physiology 151
Countries citing papers authored by Mary Jo Murnane
This map shows the geographic impact of Mary Jo Murnane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Jo Murnane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Jo Murnane more than expected).
Fields of papers citing papers by Mary Jo Murnane
This network shows the impact of papers produced by Mary Jo Murnane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Jo Murnane. The network helps show where Mary Jo Murnane may publish in the future.
Co-authorship network of co-authors of Mary Jo Murnane
This figure shows the co-authorship network connecting the top 25 collaborators of Mary Jo Murnane. A scholar is included among the top collaborators of Mary Jo Murnane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Jo Murnane. Mary Jo Murnane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 47 | |
| 2 | 9 | |
| 3 | 51 | |
| 4 | DNA hypermethylation near the transcription start site of collagen alpha2(I) gene occurs in both cancer cell lines and primary colorectal cancers. | 46 |
| 5 | 41 | |
| 6 | 23 | |
| 7 | 34 | |
| 8 | 12 | |
| 9 | 43 | |
| 10 | 39 | |
| 11 | 24 | |
| 12 | 18 | |
| 13 | 72 | |
| 14 | 2 | |
| 15 | Expression and induction of cathepsins B and D in K562 cells. | 6 |
| 16 | 16 | |
| 17 | 161 | |
| 18 | 4 | |
| 19 | 12 | |
| 20 | 44 |
About Mary Jo Murnane
Mary Jo Murnane is a scholar working on Cancer Research, Genetics and Rheumatology, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (10 papers), Peptidase Inhibition and Analysis (5 papers) and Bone and Dental Protein Studies (4 papers). The work is most often cited by research in Cancer Research (378 citations), Immunology and Allergy (106 citations) and Genetics (172 citations). Mary Jo Murnane has collaborated with scholars based in United States, Netherlands and South Korea. Frequent co-authors include Sania Shuja, Kieran Sheahan, Kwonseop Kim, Metin Özdemirli, Bernard G. Forget, Jon K. deRiel, F.H. Ruddle, Dorothy Tuan, EJ Jr Benz and Eric Michael Mazur. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.